These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4795197)

  • 21. [Study of the hypouricemic effect of benziodarone in chronic renal insufficiency].
    Ponticelli C; Locatelli F; Graziani G
    Arch Ital Urol Nefrol; 1967; 40(6):461-75. PubMed ID: 5607121
    [No Abstract]   [Full Text] [Related]  

  • 22. [Coronary diseases, hyperuricemia and benziodarone. Personal considerations].
    Veglia L
    Minerva Med; 1974 Oct; 65(72):3795-8. PubMed ID: 4608791
    [No Abstract]   [Full Text] [Related]  

  • 23. [Renal excretion of uric acid in various conditions inducing hyperuricemia].
    Cagli V; Ruotolo V; Bossini A; Bologna E
    Policlinico Prat; 1970 Feb; 77(8):245-55. PubMed ID: 5436749
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of hyperuricemia with benziodarone].
    Ravault PP; Vignon G; Lejeune E; Bouvier M; Queneau P
    Presse Therm Clim; 1970; 107(2):74-9. PubMed ID: 5468122
    [No Abstract]   [Full Text] [Related]  

  • 25. [Benziodarone therapy in hyperuricemia in the aged].
    Ravera M; Ugo C
    G Gerontol; 1970 Sep; 18(9):876-9. PubMed ID: 5517231
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of benzbromarone in uricemia and uricosuria].
    Gross A; Girard V
    Med Welt; 1972 Jan; 23(4):133-6. PubMed ID: 4551635
    [No Abstract]   [Full Text] [Related]  

  • 27. [A new uricemia-lowering agent: benziodarone. Its use in therapy of urate retention in the course of chronic renal insufficiency].
    Bossini A; De Martino Rosaroll G
    Policlinico Prat; 1969 Jul; 76(30):961-73. PubMed ID: 5402682
    [No Abstract]   [Full Text] [Related]  

  • 28. [The kidney and hyperuricemia].
    Lagrue G; Ménard J
    Presse Med (1893); 1971 Apr; 79(19):845-7. PubMed ID: 5576495
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic effectiveness of the combination allopurinol-benziodarone in the treatment of hyperuricemia].
    Pecora P; Suraci C; Dessì R; De Maria S; Assisi A
    Clin Ter; 1982 Mar; 100(5):463-76. PubMed ID: 6982797
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of gout and of certain rheumatisms with hyperuricemia caused by benziodarone].
    Gerbaux JO; Rodhain J
    Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):98-115. PubMed ID: 5302427
    [No Abstract]   [Full Text] [Related]  

  • 31. [Benziodarone in the treatment of hyperuricemia].
    Ravera M
    Clin Ter; 1970 Mar; 52(5):407-16. PubMed ID: 5421984
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F
    Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical quiz. A patient with hyperuricemia and renal failure.
    Williams T; Stine KC; Walker PD; Ilyas M; Wang Y; Blaszak RT
    Pediatr Nephrol; 2007 Jul; 22(7):948-53. PubMed ID: 17384967
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of benziodarone on hyperuricemia in gout].
    Cottet J; Vittu C
    Presse Med (1893); 1967 May; 75(26):1355-6. PubMed ID: 6026564
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical followup of the uricosuric drug--benzbromaron (author's transl)].
    Dzúrik R; Fedelesová V; Danĕková H; Hlavatá E
    Bratisl Lek Listy; 1980 Nov; 74(5):547-54. PubMed ID: 7448590
    [No Abstract]   [Full Text] [Related]  

  • 37. [Indications for and methods of allopurinol-benzbromarone combination therapy in the treatment of hyperuricemic metabolic disorders].
    Heidelmann G; Burck G; Dauterstedt W; Heinrich JJ; Ohlmer R
    Z Arztl Fortbild (Jena); 1982 Mar; 76(5):177-81. PubMed ID: 6896252
    [No Abstract]   [Full Text] [Related]  

  • 38. Allopurinol in the treatment of neoplastic disease complicated by hyperuricemia.
    Muggia FM; Ball TJ; Ultmann JE
    Arch Intern Med; 1967 Jul; 120(1):12-8. PubMed ID: 6028692
    [No Abstract]   [Full Text] [Related]  

  • 39. [Benziodarone (Amplivix) in the treatment of hyperuricemia].
    Antila V; Elsilä M
    Duodecim; 1969; 85(7):428-30. PubMed ID: 5799173
    [No Abstract]   [Full Text] [Related]  

  • 40. [Uratic retention due to chronic renal failure. Therapeutic treatment with benziodarone].
    Ponticelli C; Locatelli F; Graziani G; Brancaccio D
    Minerva Urol; 1969; 21(1):7-12. PubMed ID: 5400429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.